Viewing StudyNCT01565668



Ignite Creation Date: 2024-05-06 @ 12:22 AM
Last Modification Date: 2024-10-26 @ 10:49 AM
Study NCT ID: NCT01565668
Status: COMPLETED
Last Update Posted: 2019-12-27
First Post: 2012-03-27

Brief Title: Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Daiichi Sankyo
Organization: Daiichi Sankyo

Conditions & Keywords Data

Conditions:
Name
Leukemia Myeloid Acute
Keywords:
Name View
Refractory View
FLT3-ITD positive Acute Myeloid Leukemia AML View
AC220 View
Relapse View